Home » Topics » Disease categories and therapies » Substance use and poisoning

Substance use and poisoning
RSS

Japanese approval for fomepizole to treat ethylene glycol and methanol poisonings

Sep. 26, 2014

Soligenix awarded NIAID contract to develop heat stable RiVax vaccine

Sep. 23, 2014

Legalon Sil given FDA orphan designation for amatoxin poisoning

Sep. 22, 2014

Cellerant's development of CLT-008 supported by additional government funding

Sep. 17, 2014

NIAAA to study gabapentin enacarbil for the treatment of alcohol use disorder

Sep. 12, 2014

NIDA awards grant to support completion of phase IIa trial of ibudilast in opioid dependence

Sep. 9, 2014

Cleveland BioLabs clear to submit pre-EUA for entolimod

Sep. 4, 2014

Aldea Pharmaceuticals closes Series B financing

Aug. 26, 2014

Aeolus files IND for acute radiation syndrome candidate AEOL-10150

Aug. 22, 2014

MediciNova discloses results from phase IIa study of ibudilast in opioid dependence

Aug. 20, 2014

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 16, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...